Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
23.74
-0.02 (-0.08%)
Nov 22, 2024, 4:00 PM EST - Market closed
Phibro Animal Health Analyst Ratings
Total Analysts
3
Consensus Rating
Sell
Price Target
$19.00
Upside
-19.97%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Sell Maintains $13 → $20 | Sell | Maintains | $13 → $20 | -15.75% | Nov 12, 2024 |
JP Morgan | JP Morgan | Hold Initiates $22 | Hold | Initiates | $22 | -7.33% | Sep 10, 2024 |
B of A Securities | B of A Securities | Sell Maintains $13 → $15 | Sell | Maintains | $13 → $15 | -36.82% | Aug 30, 2024 |
Barclays | Barclays | Sell Maintains $10 → $13 | Sell | Maintains | $10 → $13 | -45.24% | May 10, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | -32.60% | Nov 9, 2023 |
Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | -11.54% | Sep 1, 2023 |
Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -28.39% | Aug 31, 2023 |
Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | -11.54% | Aug 29, 2023 |
Morgan Stanley | Morgan Stanley | Hold Reiterates $18 | Hold | Reiterates | $18 | -24.18% | Jul 27, 2023 |
Morgan Stanley | Morgan Stanley | Hold Maintains $19 → $18 | Hold | Maintains | $19 → $18 | -24.18% | May 4, 2023 |
Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $19 | Hold | Maintains | $20 → $19 | -19.97% | Feb 9, 2023 |
Roth Capital | Roth Capital | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | -24.18% | Dec 21, 2022 |
Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $20 | Hold | Maintains | $21 → $20 | -15.75% | Nov 10, 2022 |
Barclays | Barclays | Sell Maintains $22 → $17 | Sell | Maintains | $22 → $17 | -28.39% | Sep 16, 2022 |
Morgan Stanley | Morgan Stanley | Hold Maintains $23 → $21 | Hold | Maintains | $23 → $21 | -11.54% | Aug 26, 2022 |
Barclays | Barclays | Hold → Sell Downgrades $22 | Hold → Sell | Downgrades | $22 | -7.33% | Jul 25, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.